Characterization of adverse cutaneous effects in the setting of enfortumab vedotin for metastatic urothelial carcinoma: A retrospective review.

Authors :: Malik R
Xiang DH
Riew GJ
Sanchez-Melendez S
Afvari S
LeBoeuf NR
Nambudiri VE
Source :: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Oct; Vol. 91 (4), pp. 753-755. Date of Electronic Publication: 2024 Jun 21.
Publication Year :: 2024
Abstract: Competing Interests: Conflicts of interest None disclosed.

Subjects :: Humans
Retrospective Studies
Male
Aged
Female
Drug Eruptions etiology
Middle Aged
Urinary Bladder Neoplasms drug therapy
Urinary Bladder Neoplasms pathology
Antineoplastic Agents, Immunological adverse effects
Antineoplastic Agents, Immunological therapeutic use
Aged, 80 and over
Antibodies, Monoclonal adverse effects
Antibodies, Monoclonal therapeutic use
Carcinoma, Transitional Cell drug therapy
Carcinoma, Transitional Cell secondary
Carcinoma, Transitional Cell pathology

Full Text Access

Tools